Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1264 Records) |
| Query Trace: Disease and KRAS[original query] |
|---|
| KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers. JCO precision oncology 2024 12 8 e2400263. Rebecca Gelfer, Aiste Gulla, Hannah L Kalvin, Yi Song, James Harding, Ghassan K Abou-Alfa, Eileen M O'Reilly, Wungki Park, Rohit Chandwani, Alice Wei, Peter Kingham, Jeffrey Drebin, Vinod Balachandran, Michael D'Angelica, Kevin Soares, Mithat Gonen, William R Jarnag |
| Treatment of stage IV colorectal cancer: A retrospective cohort study assessing whether failure of first?line treatment indicates failure of second?line treatment. Molecular and clinical oncology 2024 12 22 (1): 10. Hanna Peyerl, Gudrun Kreye, Martin Pecherstorfer, Josef Sing |
| Decoding KRAS mutation in non-small cell lung cancer patients receiving immunotherapy: A retrospective institutional comparison and literature review. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108051. S Berenice Urtecho, Leonardo Provenzano, Andrea Spagnoletti, Achille Bottiglieri, Chiara Pircher, Giacomo Massa, Caterina Sposetti, Claudia Proto, Marta Brambilla, Mario Occhipinti, Laura Mazzeo, Teresa Beninato, Rita Leporati, Claudia Giani, Chiara Cavalli, Roberta Serino, Marco Meazza Prina, Anna Bassetti, Vincenzo Nasca, Rosa Maria di Mauro, Alice Abate, Sara Manglaviti, Andra Diana Dumitrascu, Giorgia Di Liberti, Teresa Serra Cassano, Monica Ganzinelli, Sulin Wu, Marina Chiara Garassino, Filippo G M de Braud, Giuseppe Lo Russo, Arsela Prel |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Limited Efficacy of Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients with Rare RAS Variants: Analysis of the C-CAT Database. Current issues in molecular biology 2024 12 46 (12): 14476-14486. Shuhei Suzuki, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, Tadahisa Fukui, Takashi Yoshio |
| Unraveling the Genetic Landscape of Langerhans Cell Histiocytosis in Korean Patients: Comprehensive Insights from Mutational Profiles and Clinical Correlations. Cancer research and treatment 2024 12 . Kyung-Nam Koh, Ha Ra Jun, Ji-Young Lee, Ji Young Kim, Su Hyun Yoon, Young Kwon Koh, Sung Han Kang, Hyery Kim, Ho Joon Im, Sung-Min Ch |
| Clinical and genetic drivers of oligo-metastatic disease in colon cancer. Neoplasia (New York, N.Y.) 2024 12 60 101111. Alessandro Ottaiano, Mariachiara Santorsola, Roberto Sirica, Annabella Di Mauro, Antonella Di Carlo, Monica Ianniello, Francesco Sabbatino, Rosa Castiello, Francesca Del Peschio, Marco Cascella, Francesco Perri, Maurizio Capuozzo, Nicola Martucci, Edoardo Mercadante, Valentina Borzillo, Rossella Di Franco, Francesco Izzo, Vincenza Granata, Carmine Picone, Antonella Petrillo, Massimiliano Berretta, Salvatore Stilo, Luca Tarotto, Anna Chiara Carratù, Gerardo Ferrara, Madhura Tathode, Alessia Maria Cossu, Marco Bocchetti, Michele Caraglia, Guglielmo Nasti, Giovanni Savare |
| A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108065. Ioannis Zerdes, Caroline Kamali, Berglind Johannsdottir, Miriam Blasi, Christin Assmann, Daniel Kazdal, Albrecht Stenzinger, Marcus Skribek, Simon Ekman, Petros Christopoulos, Georgios Tsakon |
| [A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2024 12 46 (11): 1038-1048. J Du, X Qiu, J Y Ni, Q L Wang, F Tong, H Z Sha, Y H Zhu, L Qi, W Cai, C Gao, X W Wei, M B Chen, Z Y Qian, M H Cai, M Tao, C L Wang, G C Zheng, H Jiang, A W Dai, J Wu, M H Zhao, X Q Li, B Lu, C B Wang, B R L |
| Association between KRAS mutation and alcohol consumption in Brazilian patients with colorectal cancer. Scientific reports 2024 11 14 (1): 26445. Bianca Gomes-Fernandes, Luísa Martins Trindade, Marcela de Castro Bastos Rodrigues, João Pedro Duarte Cardoso, Frederico Temponi Lima, Luíza Rogerio, Simone de Vasconcelos Generoso, Juliana Garcia Carneiro, Rodrigo Gomes da Silva, Renan Pedra de Souza, Luiz De Marco, Luciana Bastos-Rodrigu |
| Clinical Utility of a Novel Triplex Digital PCR Assay for Clone Monitoring in Sequential and Relapsed Pediatric B-Cell Acute Lymphoblastic Leukemia Patients. Pediatric blood & cancer 2024 11 e31443. Prateek Bhatia, Rozy Thakur, Sreejesh Sreedharanunni, Minu Singh, Meenakshi Malhotra, Swati Arora, Ashish George, Amita Treh |
| Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 11 . Guopan Yu, Yu Zhang, Sijian Yu, Zhao Yin, Guangyang Weng, Na Xu, Xin Du, Dongjun Lin, Jie Xiao, Zhiqiang Sun, Hongyu Zhang, Xinquan Liang, Ziwen Guo, Weihua Zhao, Min Dai, Zhiping Fan, Li Xuan, Hui Liu, Dan Xu, Jieyu Ye, Xuejie Jiang, Pengcheng Shi, Hua Jin, Qifa L |
| Genetic Testing of Japanese Patients with Serrated Polyposis Syndrome: A Multicentric Study. Journal of the anus, rectum and colon 2024 10 8 (4): 348-355. Akinari Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Yasushi Okazaki, Hideki Ishikawa, Kiwamu Akagi, Hideyuki Ishi |
| A Novel AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53 NGS Assay: A Non-Invasive Tool to Monitor Resistance Mechanisms to Hormonal Therapy and CDK4/6 Inhibitors. Biomedicines 2024 10 12 (10): . Alessandra Virga, Caterina Gianni, Michela Palleschi, Davide Angeli, Filippo Merloni, Roberta Maltoni, Paola Ulivi, Giovanni Martinelli, Ugo De Giorgi, Sara Bravacci |
| Prognostic Role of Specific KRAS Mutations Detected in Aspiration and Liquid Biopsies from Patients with Pancreatic Cancer. Genes 2024 10 15 (10): . Tereza Hálková, Bohuš Bungani?, Eva Traboulsi, Marek Minárik, Miroslav Zavoral, Lucie Benešo |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Prognostic value of the TP53 mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX. Therapeutic advances in medical oncology 2024 10 16 17588359241290482. Min Kyu Kim, In Rae Cho, Yooeun Kim, Jin Ho Choi, Kwangrok Jung, Jaihwan Kim, Sheehyun Kim, Hongseok Yun, Jeesun Yoon, Do-Youn Oh, Kwangsoo Kim, Sang Hyub L |
| Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA oncology 2024 10 . Maria E Cabanillas, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D Williams, Mark Zafereo, Jennifer R Wang, Charles Lu, Matthew Ning, Brian A McKinley, Scott E Woodman, Dzifa Duose, Gary B Gunn, Naifa L Busaidy, |
| Targeted Genetic Sequencing Analysis of 223 Cases of Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Shows Survival Related to GNAS and KRAS Status. Cancer medicine 2024 10 13 (20): e70340. Jane Gibson, Reuben J Pengelly, Amatta Mirandari, Konstantinos Boukas, Sophia Stanford, Thomas Desmond Cecil, Faheez Mohamed, Sanjeev Paul Dayal, Alexios Tzivanakis, Brendan John Moran, Alex Mirnezami, Norman John Carr, Sarah Enn |
| Circulating tumor DNA in conjunctival melanoma: landscape and surveillance value. American journal of ophthalmology 2024 10 . Hao Tian, Hanhan Shi, Jie Chen, Tianyu Zhu, Ziyue Huang, Chunyan Zong, Shichong Jia, Jing Ruan, Shengfang Ge, Haihua Yuan, Yanjie Zhang, Bin Jiang, Rong Liu, Renbing Jia, Xianqun Fan, Shiqiong |
| TAS-102 (trifluridine/tipiracil) plus bevacizumab versus TAS-102 alone as salvage treatment options for metastatic colorectal cancer in routine clinical practice. Frontiers in oncology 2024 10 14 1450732. Ji Eun Shin, Sung Hee Lim, Jeeyun Lee, Ho Yeong Lim, Young Suk Park, Seung Tae K |
| Molecular Profiling of Low-Grade Appendiceal Mucinous Neoplasms (LAMN). Genes, chromosomes & cancer 2024 10 63 (10): e23270. Julia Doll, Katja Maurus, Franziska Köhler, Niels Matthes, Johan F Lock, Christoph-Thomas Germer, Andreas Rosenwald, Armin Wiegeri |
| Afatinib plus bevacizumab combination after osimertinib resistance in advanced EGFR-mutant non-small cell lung cancer: Phase II ABCD-study. Lung cancer (Amsterdam, Netherlands) 2024 10 197 107988. Akito Hata, Nobuyuki Katakami, Naoto Takase, Kayoko Kibata, Yuta Yamanaka, Motohiro Tamiya, Masahide Mori, Takashi Kijima, Satoshi Morita, Kazuko Sakai, Kazuto Nish |
| Colorectal Cancer and Its Microenvironment: A Brief Review. Medical journal of the Islamic Republic of Iran 2025 1 38 108. Nauryzbay M Imanbayev, Arip K Koyshybaev, Nurgul M Kereyeva, Marzhan A Aitmagambetova, Azamat B Zharylgap |
| Mutational and co-mutational landscape of early onset colorectal cancer. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2025 1 1-13. Jumanah Yousef Alshenaifi, Guglielmo Vetere, Giulia Maddalena, Mahmoud Yousef, Michael G White, John Paul Shen, Eduardo Vilar, Christine Parseghian, Arvind Dasari, Van Karlyle Morris, Ryan Huey, Michael J Overman, Robert Wolff, Kanwal P Raghav, Jason Willis, Kristin Alfaro, Andy Futreal, Y Nancy You, Scott Kope |
| Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival. Nature medicine 2025 1 . Anna M Varghese, Maria A Perry, Joanne F Chou, Subhiksha Nandakumar, Daniel Muldoon, Amanda Erakky, Amanda Zucker, Christopher Fong, Miika Mehine, Bastien Nguyen, Olca Basturk, Fiyinfolu Balogun, David P Kelsen, A Rose Brannon, Diana Mandelker, Efsevia Vakiani, Wungki Park, Kenneth H Yu, Zsofia K Stadler, Mark A Schattner, William R Jarnagin, Alice C Wei, Debyani Chakravarty, Marinela Capanu, Nikolaus Schultz, Michael F Berger, Christine A Iacobuzio-Donahue, Chaitanya Bandlamudi, Eileen M O'Reil |
| Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML. HemaSphere 2025 1 9 (1): e70060. Sibylle Cocciardi, Maral Saadati, Nina Weiß, Daniela Späth, Silke Kapp-Schwoerer, Isabelle Schneider, Annika Meid, Verena I Gaidzik, Sabrina Skambraks, Walter Fiedler, Michael W M Kühn, Ulrich Germing, Karin T Mayer, Michael Lübbert, Elli Papaemmanuil, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Axel Benner, Hartmut Döhner, Konstanze Döhn |
| Subclonal TP53 and KRAS variants combined with poor treatment response identify ultra-high-risk pediatric T-ALL patients. Blood advances 2025 1 . Tamara Kempter, Paulina Richter-Pechanska, Katarzyna Michel, Tobias Rausch, Bü?ra Erarslan Uysal, Cornelia Eckert, Martin Zimmermann, Martin Stanulla, Martin Schrappe, Gunnar Cario, Stefan Köhrer, Andishe Attarbaschi, Jan O Korbel, Joachim B Kunz, Andreas Kuloz |
| Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRAS Mutation from Phase 1 and Phase 2 Studies. The AAPS journal 2025 1 27 (1): 26. Mario Nagase, Brett Houk, Irene Vuu, Panli Cardona, Sandeep Dutta, Chih-Wei L |
| Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population. Pathology, research and practice 2025 1 266 155806. Inwoo Hwang, So Young Kang, Deok Geun Kim, Kee-Taek Jang, Kyoung-Mee K |
- Page last reviewed:Feb 1, 2024
- Content source: